Arcus Biosciences (RCUS)'s 30-day implied volatility (IV30) was 52.3% at the close on November 10, 2026, down from 53.6% the day before, against a 52-week range of 36.3% to 98.9%. Its 20-day historical volatility was 71.5%.
Data as of November 10, 2026.